Rico, Juan Felipe http://orcid.org/0000-0002-7522-9542
Caterino, Jeffrey M.
Stephens, Julie A.
Abar, Beau
Adler, David
Bastani, Aveh
Bernstein, Steven L.
Bischof, Jason J.
Coyne, Christopher J.
Grudzen, Corita R.
Henning, Daniel J.
Hudson, Matthew F.
Klotz, Adam D.
Lyman, Gary H.
Madsen, Troy E.
Reyes, Cielito C.
Ryan, Richard J.
Shapiro, Nathan I.
Swor, Robert
Thomas, Charles R. Jr.
Venkat, Arvind
Wilson, Jason
Yeung, Sai-Ching Jim
Yilmaz, Sule
Baugh, Christopher W.
Article History
Received: 21 July 2023
Accepted: 5 November 2023
First Online: 30 November 2023
Declarations
:
: Each participating site’s institutional review board approved all study procedures.
: N/A.
: Dr. Rico has funding from Novartis, Global Blood Therapeutics, and Daichi-Sancho. Dr. Yeung was a member of an expert panel for Celgene, Inc. Dr. Yeung had funding support from Bristol-Myers Squibb, Inc. and Depomed, Inc. (now Assertio Therapeutics, Inc.). Dr. Bischof receives funding support from Abbott, Beckman Coulter, CalciMedica, Comprehensive Research Associates, and RCE. Dr. Baugh is a speaker for Roche Diagnostics; advisor for Lucia Health Guidelines; advisory board member for Roche Diagnostics, Bristol Myers Squib, InCarda Therapeutics, Salix Pharmaceuticals, and AcelRx Pharmaceuticals; consultant/grant recipient for Visby Medical; and consultant for Torus Biosystems. The other authors declare that they have no competing interests.